Access & reimbursement

RAS Has Finally Hit Pancreatic Cancer. Now Access Has to Catch Up.

Polycythemia Vera Gets a First-in-Class Option. Patients Need More Than Blood Draws.

HER2 Testing Just Became the Gatekeeper in Gastroesophageal Cancer

MS Gets a Cleaner BTK Signal

Mpox Finally Gets A Stockpile

Brain Tumour Surgery Is Getting Smaller. Access Cannot Stay Elite.

AMR Has An Equity Problem

Brain Tumour Surgery Is Getting Smaller. Access Cannot Stay Elite.

Canada Moves. Alzheimer’s Patients Still Wait.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
